Board summary
Key figures
60,393
Registered population
56.7% aged 18–64
26.0%
Aged 65+
ICB 21.9% · England 17.9%
2.3%
Ethnic minority (non-White)
1.4% Asian · England 9.6%
9.1%
In IMD quintile 1
ICB 9.2% · England 21.0%
~3,650
Core20 residents (est.)
Resident basis; registered basis ~5,524 · see page 3
8,506
Hypertension register
+5.18% in 3 yrs · England +5.60%
688
SMI register
42.5% of Eastbourne's
1,141
COPD register
Reviews +10.68% in 3 yrs
Forecast to 2030
9,236
Hypertension patients, 2030
+730 on today
67.1%
QRISK ≥20% on statins, 2030
+4.02pp over 3 yrs
6.5%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Asthma annual reviews trail England and fell.
Asthma review coverage is 53.6% against 65.7% in England, falling 2.5% over 2023 to 2025 (England +4.4%), leaving about 1,600 unreviewed patients.
High-risk lipid-lowering therapy sits below England.
Lipid-lowering therapy reaches 58.2% for QRISK ≥ 20% (England 63.6%) and 59.5% for CKD (England 70.3%), which may reflect recall or coding differences.
Strong heart failure reviews and BP progress.
Heart failure reviews reach 86.0% (England 78.5%), while under-80 hypertension blood pressure control rose +9.4 pp from 2023 to 2025 to 66.9% (England 67.8%).
Population, age and ethnicity
Older adults represent 26.0% of registered patients, alongside 67 catchment care homes
Across 60,393 registered patients, 26.0% (15,681 patients) are aged 65+, above Eastbourne (24.2%), NHS Sussex Integrated Care Board (21.9%) and England (17.9%). Working-age adults aged 18-64 comprise 56.7% (34,270 patients) and those aged 0-17 comprise 17.3% (10,442 patients). In associated areas, 97.7% of usual residents are White, higher than Eastbourne (90.8%), the ICB (91.0%) and England (81.1%), leaving a 2.3% ethnic minority share. This older demographic may increase demand for complex chronic care. Ethnicity figures reflect local Census residents rather than practice-recorded lists.
Age profile
65+: ICB 21.9%, England 17.9%
Ethnicity
Older people · falls rows are Eastbourne local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Eastbourne LA) | 2,325 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 83.5% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 59.9% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Eastbourne LA) | 1,221 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Eastbourne LA) | 7.7 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
PCN Core20 share is 9.1%, but concentration spans 19.4 percentage points across practices
The PCN Core20 share (patients living in the most deprived 20% of national areas) is 9.1%, below Eastbourne (19.5%), in line with NHS Sussex Integrated Care Board (9.2%), and below England (21.0%). Practice concentration spans 19.4 pp: Grove Road Surgery has the highest share at 19.4% (estimated 1,099 patients), Victoria Medical Centre holds the largest volume with an estimated 2,802 patients (10.3%), and Downlands Medical Centre has 0.0%. Practice estimates sum to 5,524 registered patients versus 3,650 resident decile 1+2 persons; dual targeting must reconcile these bases.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
688
SMI register
1.35% recorded prevalence
311
Learning disability register
0.61% recorded prevalence
67
Care homes, 2,107 beds
In the PCN catchment
9.7%
Provide unpaid care
Eastbourne, Census 2021
The PCN records 688 patients on the severe mental illness register (1.4% vs Eastbourne 1.5%, NHS Sussex Integrated Care Board 1.1%, England 1.0%) and 311 on the learning disability register (0.6% vs Eastbourne 0.8%, ICB 0.6%, England 0.6%), alongside 67 catchment care homes (2,107 beds).
Severe mental illness: physical health checks
For severe mental illness, blood pressure checks reached 74.3% (Eastbourne 74.1%, NHS Sussex Integrated Care Board 81.3%, England 83.4%) and BMI recording was 71.6% (Eastbourne 69.9%, NHS Sussex Integrated Care Board 79.7%, England 82.1%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
8,506
Hypertension register
+5.18%
Register growth, 3 yrs
Eastbourne +5.24% · England +5.60%
+9.45pp
BP control, under 80
≤140/90 · +5.94pp aged 80+
+730
More patients by 2030
Forecast 9,236 (18.44%)
Hypertension case-finding and control
The hypertension register records 8,506 patients, representing 16.7% prevalence compared to 17.5% in Eastbourne, 16.3% across NHS Sussex Integrated Care Board and 15.2% in England. Prevalence rose +5.2% (+0.8 pp) over 2023 to 2025, while England rose +5.6% (+0.8 pp). Blood pressure control in patients under 80 improved by +9.4 pp over 2023 to 2025 (England +2.1 pp) to 66.9% (England 67.8%). For patients aged 80 and over, control reached 77.2% (England 81.2%; NHS Sussex Integrated Care Board 79.2%) following a +5.9 pp rise (England +1.8 pp).
Lipids and statins
Lipid-lowering therapy reaches 58.2% for QRISK ≥ 20% (England 63.6%) and 59.5% for CKD (England 70.3%), while 65+ prescribing is 5,281 items per 1,000 (England 18,056).
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 82,812 | £2.00 | £2.42 | £1.86 | £165,624 |
| Cardiovascular (all), 2025 | 123,216 | £2.99 | £3.32 | £3.33 | £368,416 |
In 2026, 82,812 lipid-regulating items were prescribed at £2.00 each (England £1.86; Eastbourne £2.09; NHS Sussex Integrated Care Board £2.42), spending £165,624. Across these items, the PCN spent £11,594 more than at England's unit cost, but £34,781 less than at NHS Sussex Integrated Care Board's unit cost.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−2.45%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+4.49%
Asthma prevalence, PCN 3-yr % change
Asthma prevalence is 7.0% (3,385 patients; England 6.6%), but reviews fell 1.4 pp over 2023 to 2025 (England +2.8 pp) to 53.6% (England 65.7%), leaving about 1,600 unreviewed patients (calculated 1,569). Youth asthma prescribing is 1,954 items per 1,000 (England 1,488 rate), while second-hand smoke recording reached 69.8% (England 78.8%). COPD prevalence is 2.2% (1,141 patients; England 1.9%) with reviews at 72.1% (England 76.4%). This is consistent with unverified review gaps that an audit could test.
Cancer register and children's immunisation
Cancer prevalence is 5.3% (2,722 patients; England 3.8%). In Q1 2025/26 childhood immunisations, MMR dose 1 at 24 months met the 95.0% target at 95.0% (England 88.3%). However, at age five, MMR dose 2 reached 88.9% (below the 95.0% target by 6.1 pp) and the 4-in-1 booster reached 88.1% (below the 95.0% target by 6.9 pp).
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
58.5%
Sussex ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,360
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Sussex ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 56.6% | 53.2% | 19% | 1,668 |
| Breast | 86.1% | 85.4% | 23% | 1,400 |
| Bowel | 49.8% | 47.0% | 26% | 1,133 |
| Lung | 30.3% | 33.8% | 15% | 1,058 |
| Skin cancer | 95.3% | 87.8% | 17% | 698 |
In 2022, 58.5% of staged cancers across NHS Sussex ICB were diagnosed at stage 1 or 2 (4,799 of 8,209 known-stage cases), above England's 55.3% (16.5 pp below the 75.0% national ambition). Known stage was recorded for 64.3% of registered cancers (8,209 of 12,766), trailing England (67.0%). Early presentation varied by site: lung was 30.3% and bowel was 49.8%, while breast reached 86.1%. Reaching 75.0% at ICB level would require about 1,360 additional early-stage diagnoses annually. PCN cervical screening is 66.3% (England 66.8%). These system metrics describe wider health economy staging rather than PCN diagnostic delivery.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In Jul 2026, East Sussex Healthcare NHS Trust met the 28-day faster diagnosis standard at 84.2% (England 79.3%) and the 31-day treatment standard at 98.2% (England 92.5%). However, its 62-day referral-to-treatment standard was 67.0% (18.0 pp below the 85.0% standard; England 71.2%; NHS Surrey and Sussex Integrated Care Board 71.5%; University Hospitals Sussex NHS Foundation Trust 65.2%; Maidstone and Tunbridge Wells NHS Trust 87.4%). For diagnostics, 5.3% of patients waited 6+ weeks at the trust, outperforming University Hospitals Sussex NHS Foundation Trust (12.9%) and England (23.1%). These figures reflect acute provider operational pressures rather than PCN performance.
| Pathways within standard (%) | East Sussex Healthcare | Sussex | Maidstone and Tunbridge Wells | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 84.20 | 74.01 | 81.78 | 79.29 | 79.32 |
| 31-day treatment (96%) | 98.19 | 76.79 | 98.35 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 67.04 | 65.20 | 87.43 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Sussex Healthcare | Sussex | Maidstone and Tunbridge Wells | England |
|---|---|---|---|---|
| MRI | 6.48 | 5.62 | 0.92 | 21.40 |
| CT | 0.48 | 8.57 | 0.51 | 9.92 |
| Echocardiography | 21.94 | 0.39 | 2.57 | 28.48 |
| Colonoscopy | 0.74 | 39.35 | 19.80 | 30.83 |
| Gastroscopy | 0.31 | 20.02 | 24.03 | 29.02 |
| All 15 DM01 tests | 5.27 | 12.95 | 6.42 | 23.14 |
| Community services activity | East Sussex residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 100,740 | 309,615 |
| Referrals | 17,285 | 66,930 |
| Patients with a contact | 25,880 | 85,660 |
Community services (residents of East Sussex), Jun 2026 (provisional). In Jun 2026 (provisional), community health service contacts for Eastbourne borough residents totalled 100,740, with 68,465 contacts among adults aged 65+, representing 68% of all recorded activity. These data reflect borough-level community contacts rather than PCN-specific delivery, underscoring heavy community care demands across an older population where PCN recorded cancer prevalence stands at 5.3%.
Practice variation and patient experience
Practice variation and patient experience
Clinical QOF achievement ranges from 99.3% at Victoria Medical Centre to 100.0% at Downlands Medical Centre and Manor Park Medical Centre, with Grove Road Surgery at 99.9%. Vaccination and immunisation spans 51.9 pp, from 48.1% at Grove Road Surgery to 100.0% at Victoria Medical Centre (England 55.2%).
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Victoria | 107 | 10.3 | 51.0% | 78.3% | 82.1% |
| Grove Road Surgery | 98 | 19.4 | 65.7% | 70.9% | 75.0% |
| Downlands | 109 | 0.0 | 30.0% | 72.7% | 68.1% |
| Manor Park | 96 | 9.4 | 40.0% | 63.1% | 60.5% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Asthma reviews fell 2.5% over three years while heart failure reviews rose +22.7%
Over 2023 to 2025, the PCN lagged England most on recording alcohol consumption in psychosis, which fell 4.2 pp (England +5.4 pp), and asthma reviews, down 2.5% (England +4.4%). In contrast, heart failure reviews rose +22.7% (England +8.7%) to 86.0% (England 78.5%), while under-80 blood pressure control rose +9.4 pp (England +2.1 pp) to 66.9%. These diverging trends may suggest progress in cardiovascular monitoring, whereas respiratory follow-up and physical health checks for severe mental illness could reflect operational or recall variations not yet verified locally.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Alcohol record (psychosis)
Asthma reviews
Dementia register
BP check (SMI)
Hypertension register
Heart failure reviews
BP control, under 80
COPD reviews
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Eastbourne | Asset | PCN | Eastbourne |
|---|---|---|---|---|---|
| Care homes (catchment) | 67 (2,107 beds) | n/a | Schools (catchment) | 56 | n/a |
| Children's centres | 1 | 2 | Places of worship | 62 | 46 |
| Libraries | 5 | 3 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | 1 | 1 | Carers support groups (VCS) | 1 | 1 |
| Primary schools (LA maintained) | 10 | 8 | Primary academies | 19 | 22 |
| Special schools | 1 | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma review recall
Asthma review coverage is 53.6% (England 65.7%; ICB 62.5%; Eastbourne 52.3%), falling 1.4 pp (2.5% relative; England +2.8 pp, +4.4%) over 2023 to 2025, leaving about 1,600 patients unreviewed (1,569). For discussion: practices could run a single-template asthma recall prioritising high-prescribing cohorts and offering flexible review slots. Low cost, quick to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Pharmacist-led lipid therapy review
Lipid-lowering therapy is 58.2% for QRISK ≥ 20% (England 63.6%; ICB 60.0%), 59.5% for CKD (England 70.3%), and 79.1% for diabetes with CVD (England 84.4%). For discussion: PCN pharmacists could review high-risk cardiovascular, renal and hypertension (8,506 patients) cohorts not currently on statins. Moderate effort to run.
Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.
Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.
Option 3
Combined SMI physical health checks
Across 688 SMI register patients, BP checks reached 74.3% (England 83.4%; ICB 81.3%), BMI recording reached 71.6% (England 82.1%), and psychosis alcohol recording reached 68.0% (England 81.8%). For discussion: practices could bundle all physical checks into single appointments with outreach leads and raise shared recording with mental health partners. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Older adult anticipatory care (p2) | Aged 65+ | Neighbourhood health framework · NHS vaccination strategy | PCN |
| Two-track Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check audit (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Older hypertension clinical review (p5) | Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool immunisation recall outreach (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening uptake improvement (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Option 1 · Structured asthma review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
| Option 2 · Pharmacist-led lipid therapy review (p12) | Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapy · Patients with diabetes and a history of CVD (excl. haem. stroke) treated with a statin (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Option 3 · Combined SMI physical health checks (p12) | Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs) | MHIS · From Harm to Hope | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
